Mean analyst price target for vTv Therapeutics implies a 31.6% upside. Analysts are showing strong agreement in raising earnings estimates, which supports upside despite the mean target's limited historical reliability. This is a cautious positive signal for the equity with modest expected market impact.
Mean analyst price target for vTv Therapeutics implies a 31.6% upside. Analysts are showing strong agreement in raising earnings estimates, which supports upside despite the mean target's limited historical reliability. This is a cautious positive signal for the equity with modest expected market impact.
AI-powered research, real-time alerts, and portfolio analytics for institutional investors.
Request a DemoOverall Sentiment
mildly positive
Sentiment Score
0.15
Ticker Sentiment
